Journal of Physiology and Biochemistry

, Volume 65, Issue 4, pp 369–376

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

  • M. T. Macarulla
  • G. Alberdi
  • S. Gómez
  • I. Tueros
  • C. Bald
  • V. M. Rodríguez
  • J. A. Martínez
  • M. P. Portillo


Recently resveratrol, a compound naturally occurring in various plants, has been proposed as a potential anti-obesity compound. The aim of the present work was to analyse the effects of different doses of resveratrol on body fat and serum parameters in rats. Thirty-two male Sprague-Dawley rats were randomly divided into four groups and fed on a hypercaloric diet for 6 weeks. The doses oftrans-resveratrol used were 6, 30 and 60 mg/kg body weight/d in RSV1, RSV2 and RSV3 groups respectively. The stability of resveratrol when added to the diet was evaluated. Blood samples were collected, and white adipose tissue from different anatomical locations, interscapular brown adipose tissue, gastrocnemious muscles and liver were weighed. Commercial kits were used to measure serum cholesterol, glucose, triacylglycerols and non-esterified fatty acids. While the lowest dose did not have a body fat reducing effect, the intermediate dose reduced all the white adipose depots. The highest dose significantly reduced mesenteric and subcutaneous depots but not epididymal and perirenal tissues. Although the reduction in all the anatomical locations analysed was 19% in the RSV3 group, in the RSV2 group it was 24%. No significant differences among the experimental groups were found in brown adipose tissue, gastrocnemious muscle or liver weights. Serum parameters were not affected by resveratrol intake because no differences among the experimental groups were observed. These results suggest that resveratrol is a molecule with potential anti-obesity effect. The most effective of the three experimental doses was 30 mg/kg body weight/d.

Key words

Resveratrol Body fat Hypercaloric diet Rat 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adams, K.F., Schatzkin, A., Harris, T.B., Kipnis, V. et al. (2006): Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med, 355, 763–778.CrossRefPubMedGoogle Scholar
  2. 2.
    Ahn, J., Cho, I., Kim, S., Kwon, D., Ha, T. (2008): Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol, 49, 1019–1028.CrossRefPubMedGoogle Scholar
  3. 3.
    Bai, L., Pang, W.J., Yang, Y.J. and Yang, G.S. (2008): Modultion of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem, 307, 129–140.CrossRefPubMedGoogle Scholar
  4. 4.
    Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A. et al. (2006): Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337–342.CrossRefPubMedGoogle Scholar
  5. 5.
    Caruso, F., Tanski, J., Villegas-Estrada, A., Rossi, M. (2004): Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem, 52, 7279–7285.CrossRefPubMedGoogle Scholar
  6. 6.
    Cucciolla, V., Borriello, A., Oliva, A., Galletti, P. et al. (2007): Resveratrol: from basic science to the clinic. Cell Cycle, 6, 2495–2510.CrossRefPubMedGoogle Scholar
  7. 7.
    Debant, A., Guerre-Millo, M., Le Marchand-Brustel, Y., Freychet, P. et al. (1987): Insulin receptor kinase is hyperresponsive in adipocytes of young obese Zucker rats. Am J Physiol, 252, E273-E278.PubMedGoogle Scholar
  8. 8.
    Frémont, L. (2000): Biological effects of resveratrol. Life Sci, 66, 663–673.CrossRefPubMedGoogle Scholar
  9. 9.
    Goldberg, D.M., Ng, E., Yan, J., Karumanchiri, A. et al.(1996): Regional differences in resveratrol isomer concentrations from wines from various cultivars. J Wine Res, 7, 13–24.CrossRefGoogle Scholar
  10. 10.
    Goswami, S. K. and Das, D.K. (2009): Resveratrol and chemoprevention. Cancer Lett, 284, 1–6.CrossRefPubMedGoogle Scholar
  11. 11.
    James, P.T., Rigby, N. and Leach, R. (2004): The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil, 11, 3–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Kolouchová-HanzlÍková, I., Melzoch, K., Filip, V. and Smidrkal, J. (2004): Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines. Food Chem, 87, 151–158.CrossRefGoogle Scholar
  13. 13.
    Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H. et al. (2006): Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127, 1109–1122.CrossRefPubMedGoogle Scholar
  14. 14.
    Langcake, P. and Pryce, R.J. (1974): The production of resveratrol byVitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Phatol, 9, 77–86.Google Scholar
  15. 15.
    Larsen, T.M., Toubro, S. and Astrup, A. (2003): Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res, 44, 2234–2241.CrossRefPubMedGoogle Scholar
  16. 16.
    Leonard, S. S., Xia, C., Jiang, B.H., Stinefelt, B. et al. (2003): Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun, 309, 1017–1026.CrossRefPubMedGoogle Scholar
  17. 17.
    Montsko, G., Pour Nikfardjam, M.S., Szabo, Z., Boddi, K. et al. (2008): Determination of products derived from trans-resveratrol UV photoisomerisation by means of HPLC-APCI-MS. J Photochem Photobiol A: Chem, 196, 44–50.CrossRefGoogle Scholar
  18. 18.
    Navarro, V., Fernández-Quintela, A., Churruca, I. and Portillo, M.P. (2006): The body-fat lowering effect of conjugated linoleic acid: a comparison between animal and human studies. J Physiol Biochem, 62, 137–147.CrossRefPubMedGoogle Scholar
  19. 19.
    Phillips, F.C. and Cleary, M.P. (1994): metabolic measurements among homozygous (fa/fa) obese, heterozygous (Fa/fa) lean and homozygous (Fa/Fa) lean Zucker rat pups at 17 days of age. J Nutr, 124, 1230–1237.PubMedGoogle Scholar
  20. 20.
    Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A. et al. (2004): Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature, 429, 771–776.CrossRefPubMedGoogle Scholar
  21. 21.
    Poussier, B., Cordova, A.C., Becquemin, J.P. and Sumpio, B. E. (2005): Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg, 42, 1190–1197.CrossRefPubMedGoogle Scholar
  22. 22.
    Rayalam, S., Della-Fera, M.A. and Baile, C.A. (2008): Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem, 19, 717–726.CrossRefPubMedGoogle Scholar
  23. 23.
    Rayalam, S., Della-Fera, M.A., Yang, J.Y., Park, H.J. et al. (2007): Resveratrol potentiates genistein’s antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr, 137, 2668–2673.PubMedGoogle Scholar
  24. 24.
    Rivera, L., Morón, R., Zarzuelo, A., Galisteo, M. (2009): Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol, 77, 1053–1063.CrossRefPubMedGoogle Scholar
  25. 25.
    Salas-Salvadó, J., Márquez-Sandoval, F. and Bulló, M. (2006): Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr, 46, 479–488.CrossRefPubMedGoogle Scholar
  26. 26.
    Signorelli, P. and Ghidoni, R. (2005): Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem, 16, 449–466.CrossRefPubMedGoogle Scholar
  27. 27.
    Tresaco, B., Bueno, G., Moreno, L.A., Garagorri, J.M. and Bueno, M. (2003): Insulin resistance and impaired glucose tolerance in obese children and adolescents. J Physiol Biochem, 59, 217–223.CrossRefPubMedGoogle Scholar
  28. 28.
    Zamora-Ros, R., Andrés-Lacueva, C., Lamuela-Raventós, R.M., Berenguer, T. et al. (2008): Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Brit J Nutr, 100, 188–196.CrossRefPubMedGoogle Scholar
  29. 29.
    Zang, M., Xu, S., Maitland-Toolan, K.A., Zucollo, A., Hou, X. et al. (2006): Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes, 55, 2180–2191.CrossRefPubMedGoogle Scholar

Copyright information

© Universidad de Navarra 2009

Authors and Affiliations

  • M. T. Macarulla
    • 1
  • G. Alberdi
    • 1
  • S. Gómez
    • 1
  • I. Tueros
    • 2
  • C. Bald
    • 2
  • V. M. Rodríguez
    • 1
  • J. A. Martínez
    • 3
  • M. P. Portillo
    • 1
  1. 1.Department of Nutrition and Food Sciences, Faculty of PharmacyUniv. of the Basque CountryVitoria
  2. 2.New Food Products Area, Food Research DivisionAZTI-TecnaliaDerio
  3. 3.Department of Nutrition and Food Sciences, Physiology and ToxicologyUniversidad de NavarraPamplonaSpain

Personalised recommendations